These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6548211)

  • 1. RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo.
    Adams GE; Ahmed I; Sheldon PW; Stratford IJ
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1653-6. PubMed ID: 6548211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
    Adams GE; Ahmed I; Sheldon PW; Stratford IJ
    Br J Cancer; 1984 May; 49(5):571-7. PubMed ID: 6547051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo.
    Ahmed I; Jenkins TC; Walling JM; Stratford IJ; Sheldon PW; Adams GE; Fielden EM
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1079-81. PubMed ID: 3755711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analogues.
    Walling JM; Stratford IJ; Adams GE; Silver AR; Ahmed I; Jenkins TC; Fielden EM
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1083-6. PubMed ID: 3755712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The radiosensitizing and toxic effects of RSU-1069 on hypoxic cells in a murine tumor.
    Chaplin DJ; Durand RE; Stratford IJ; Jenkins TC
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1091-5. PubMed ID: 3755714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation of the radiosensitizing efficiency of RSU-1069 with pre-irradiation contact times: a rapid mix study.
    Austen KR; Jenner TJ; O'Neill P; Fielden EM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Aug; 52(2):281-8. PubMed ID: 3497125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tumour hypoxia post-irradiation: a method for increasing the sensitizing efficiency of misonidazole and RSU 1069 in vivo.
    Stratford IJ; Adams GE; Godden J; Howells N
    Int J Radiat Biol; 1989 Mar; 55(3):411-22. PubMed ID: 2564037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
    Siemann DW; Maddison K; Wolf K
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative DNA damage and repair induced by misonidazole, CB 1954 and RSU 1069.
    Dale LD; Widdick DA; Edwards DI; Biol GI
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):995-9. PubMed ID: 2649469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
    Hill RP; Gulyas S; Whitmore GF
    Br J Cancer; 1986 Jun; 53(6):743-51. PubMed ID: 3755053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of DNA damage in mammalian cells upon bioreduction of the nitroimidazole-aziridines RSU-1069 and RSU-1131.
    Jenner TJ; Sapora O; O'Neill P; Fielden EM
    Biochem Pharmacol; 1988 Oct; 37(20):3837-42. PubMed ID: 3190731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
    Siemann DW
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1115-8. PubMed ID: 2703392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
    Cole S; Stratford IJ; Adams GE; Fielden EM; Jenkins TC
    Radiat Res; 1990 Oct; 124(1 Suppl):S38-43. PubMed ID: 2236508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of mutations in V79-4 mammalian cells under hypoxic and aerobic conditions by the cytotoxic 2-nitroimidazole-aziridines, RSU-1069 and RSU-1131. The influence of cellular glutathione.
    Sapora O; Paone A; Maggi A; Jenner TJ; O'Neill P
    Biochem Pharmacol; 1992 Oct; 44(7):1341-7. PubMed ID: 1417957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the toxicity of RSU-1069.
    Whitmore GF; Gulyas S
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1219-22. PubMed ID: 3755716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oxygenation, pH and hyperthermia on RSU-1069 in vitro and in vivo with radiation in the FSaIIC murine fibrosarcoma.
    Teicher BA; Herman TS; Holden SA; Rudolph MB
    Cancer Lett; 1991 Aug; 59(2):109-17. PubMed ID: 1884367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of the mixed-function radio- and chemosensitizers CB 1954 and RSU 1069.
    Workman P; Walton MI
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1307-10. PubMed ID: 6547936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The repair of DNA damage induced in V79 mammalian cells by the nitroimidazole-aziridine, RSU-1069. Implications for radiosensitization.
    Jenner TJ; O'Neill P; Crump PW; Fielden EM; Sapora O; Santodonato L
    Biochem Pharmacol; 1991 Oct; 42(9):1705-10. PubMed ID: 1930296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo radiosensitizing effects of 2-nitroimidazole derivatives with sugar component.
    Murayama C; Tanaka N; Miyamoto Y; Sakaguchi M; Mori T
    Strahlenther Onkol; 1987 Jun; 163(6):385-90. PubMed ID: 3603366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differential cytotoxicity of RSU 1069: cell survival studies indicating interaction with DNA as a possible mode of action.
    Stratford IJ; Walling JM; Silver AR
    Br J Cancer; 1986 Mar; 53(3):339-44. PubMed ID: 3754453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.